Penn researchers find transcatheter aortic valve replacement better for patients with severe aortic stenosis

(University of Pennsylvania School of Medicine) A new study conducted by researchers in the Perelman School of Medicine at the University of Pennsylvania, in partnership with Edwards Lifesciences, the Cardiovascular Research Foundation, and 50 centers across the United States and Canada, found that for patients at intermediate-risk for open-heart surgery, transcatheter aortic valve replacement (TAVR) with the latest generation of balloon-expandable device -- SAPIEN 3 -- is superior to surgery, r...